The general escalation pattern from published protocols looks like this: Initiation phase (weeks 1-4): Starting doses ranged from 0.5 mg to 2 mg once weekly, depending on the study arm
Microneedle treatment increased permeation to 4.4 ug/cm2/h
In addition, the defensive mechanism of taurine was demonstrated when it inhibited MMP-9 in brain microvessels via inactivating NF-B and CD147 signaling [104]
Examples of general laboratory contexts include identity verification, internal reference comparison, stability tracking, documentation validation, and standardized method development
A main effect of day, irrespective of group, was observed for body weight in both young and aged animals, with increasing values over time (Table 1)
(PubMed) Levine M, Conry-Cantilena C, Wang Y, et al